These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22896660)

  • 21. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma N-terminal pro-B-type natriuretic peptide reference value in subjects without heart diseases].
    Wei BQ; Yang YJ; Zhang J; Zhang CL; Xu B; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):804-8. PubMed ID: 20128378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The N-terminal pro-brain natriuretic peptide (NT-proBNP) assay with the Stratus CS analyzer].
    Chenevier-Gobeaux C; Guillot D; Ursulet J; Paul JL; Ekindjian OG; Desmoulins D; Benoit MO
    Ann Biol Clin (Paris); 2007; 65(1):77-82. PubMed ID: 17264043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP).
    Chenevier-Gobeaux C; Claessens YE; Voyer S; Desmoulins D; Ekindjian OG
    Clin Chim Acta; 2005 Nov; 361(1-2):167-75. PubMed ID: 15993397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)].
    Benoit MO; Dautezac F; Taccoen M; Paul JL
    Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL; Qiu YR; Zhou F; Feng PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association between serum NT-proBNP/hs-CRP and acute rejection after heart transplantation].
    Yin D; Huang J; Feng L; Feng GX; Hu SS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):145-8. PubMed ID: 19719993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The prognostic value of N-terminal pro-B-type natriuretic peptide in patients with severe sepsis and septic shock].
    Zhao HY; Liu F; Lu J; Liu D; An YZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):467-70. PubMed ID: 21878169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
    Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
    Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
    Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
    Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal pro-B-type natriuretic peptide with fractional excretion and clearance of sodium in relation to cardiovascular events after elective cervical spine surgery.
    Spatenkova V; Bradac O; Kazda A; Suchomel P
    Neuro Endocrinol Lett; 2011; 32(6):874-8. PubMed ID: 22286795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
    Jonsson G; Abdelnoor M; Landaas S; Muller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2006; 106(2):102-8. PubMed ID: 16636540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.